Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Aizhong Zen"'
Autor:
Yuwei Wang, Xuefeng Shan, Zhi Liang, Youlan Shan, Wenxiang Huang, Dazhi Zhang, Aizhong Zen, Xin Zhou, Yao Zhao, Xuyang Gong, Ge Xu, Xiuyu Zhang, Juan Chen, Ailong Huang
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0131337 (2015)
Viral genotype shift in chronic hepatitis B (CHB) patients during antiviral therapy has been reported, but the underlying mechanism remains elusive.38 CHB patients treated with ADV for one year were selected for studying genotype shift by both deep s
Externí odkaz:
https://doaj.org/article/204cfb116588469b8793fc60e5d5d692
Autor:
Lei Tang, Qinyi Sun, Mengyuan Li, Xiaoxiao Yu, Jinguo Meng, Yun Zhang, Yuxiao Ma, Aizhong Zeng, Zhuolan Li, Yuanyuan Liu, Xinyu Xu, Wei Guo
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundChimeric antigen receptor T (CAR-T) cell therapies have achieved remarkable success in the treatment of hematological tumors. However, given the distinct features of solid tumors, particularly heterogeneity, metabolic aggressiveness, and fe
Externí odkaz:
https://doaj.org/article/2f1b0d6cd07f4bafa638d07c2ff46620
Autor:
You-Lan Shan, Xiuyu Zhang, Xue-Feng Shan, Aizhong Zen, Wen-Xiang Huang, Xuyang Gong, Juan Chen, Da-Zhi Zhang, Zhi Liang, Ailong Huang, Ge Xu, Yao Zhao, Xin Zhou, Yuwei Wang
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 6, p e0131337 (2015)
PLoS ONE, Vol 10, Iss 6, p e0131337 (2015)
Background Viral genotype shift in chronic hepatitis B (CHB) patients during antiviral therapy has been reported, but the underlying mechanism remains elusive. Methods 38 CHB patients treated with ADV for one year were selected for studying genotype
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14e9ad6415ed7761eccaf5fe4060bf5c
https://pubmed.ncbi.nlm.nih.gov/26110616
https://pubmed.ncbi.nlm.nih.gov/26110616
Autor:
Yujiao Zhou, Feifei Liu, Chengmin Li, Guo Shi, Xiaolei Xu, Xue Luo, Yuanling Zhang, Jingjie Fu, Aizhong Zeng, Limin Chen
Publikováno v:
Journal of Immunology Research, Vol 2018 (2018)
Dendritic cells (DCs) harboring tumor-associated antigen are supposed to be a potential immunotherapy for hepatocellular carcinoma (HCC). Aspartate-β-hydroxylase (AAH), an overexpressed tumor-associated cell surface protein, is considered as a promi
Externí odkaz:
https://doaj.org/article/a43c9f2f3a07479691a24f82532a829c